Pfizer Inc. (PFE). Shares have underperformed during the past three years, rising 9.4% compared to the S&P 500’s rise of nearly 31%. The pharmaceutical company now appears to be poised to rise 10% in the coming weeks, based on technical analysis.

StockMarketNews.Today – Pfizer has not only underperformed the broader stock market, but its valuation is among the cheapest of some of the other big pharmaceuticals. Shares of Pfizer are trading at just 11.9 times 2019 earnings estimates, well below that of the S&P 500 and companies like Merck & Co. Inc.

Read More…

Pfizer Agreed To Merge Its Off-Patent Drugs Business With Mylan

Pfizer and Mylan are betting that combining Pfizer’s off-patent business, called Upjohn, with Mylan—known for the EpiPen emergency allergy shot—will provide a pathway to reignite sales growth. Shareholders of Pfizer will own 57% of the new business and the rest of it will be owned by shareholders of Mylan. The new company is expected to […]

Read More…

Drugmakers Raise Prices on Hundreds of Medicines. New analysis shows Allergan setting the pace with increases of nearly 10% on more than two dozen products

More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines. The average increase was 6.3%, according to the analysis, including increases on different doses for the same drug.

Read More…

3 Pharma Stocks to buy in 2019. The pharmaceutical sector delivers two benefits that appeal to investors: reasonable P/E ratios and growth catalysts.

Many pharma stocks have suffered as of late. Some have key drugs facing patent expirations. Meanwhile, others have sold off as trade-related fears or regulatory hurdles both domestically and abroad increase uncertainty. However, some of these companies have responded by developing new drugs. The following 3 pharma stocks appear particularly well-positioned to benefit from new drugs and demographic tailwinds in 2019.

Read More…

PG&E Reaches $11 Billion Settlement with Insurers over Deadly Wildfires

Deal Moves PG&E Closer to Bankruptcy Exit PG&E said it has reached an $11 billion settlement with insurance companies over wildfire claims, a significant step toward emerging from bankruptcy. The deal covers insurance carriers and hedge funds that were seeking compensation from PG&E for payouts insurers made to homeowners and businesses in connection with fires […]

Read More…

European Central Bank Launches New Bond-Buying Program

The European Central Bank (ECB) announced a massive new bond-buying program Thursday in a bid to stimulate the ailing euro zone economy. President Mario Draghi announced that the central bank would cut its main deposit rate by 10 basis points to -0.5%, in line with expectations. The ECB now expects interest rates to remain at […]

Read More…

Trump Raises Pressure on Fed

◊ StockMarketNews.Today – BUSINESS & FINANCIAL NEWS ◊ — … President Donald Trump urged the Federal Reserve to lower interest rates to a level typically reserved for recessions or periods of persistently weak growth, suggesting that such a setting could allow the government to refinance Treasury debt at a lower cost. Start Trading Now or Try […]

Read More…

U.S. Stocks Open Higher on Hopes for Trade Talks

◊ U.S. Stocks News Today ◊ ♦ Stock Market News Today ♦ … — U.S. stocks advanced Thursday amid renewed hopes for progress in the trade dispute between the U.S. and China. The Dow Jones Industrial Average climbed 267 points, or 1.1%. The S&P 500 added 1%, led by gains in trade-sensitive industrial and material […]

Read More…

Amgen to Buy Celgene’s Otezla for $13.4 Billion in Cash

◊ Amgen News Today ◊ ♦ Amgen Buy Otezla ♦ Stock Market News ♦ … — Amgen Inc. said it has agreed to buy Celgene Corp. ’s psoriasis treatment Otezla for $13.4 billion in cash, in a deal that would pave the way for Bristol-Myers Squibb Co. to complete its acquisition of Celgene. Amgen said Monday […]

Read More…

Home Depot Cuts Sales Forecast

{ Home Depot Cuts Sales Forecast – Stock Market News } … Home Depot Inc. lowered its sales forecast as the company warned that rising material costs as well as the potential effects of tariffs on U.S. consumers could weigh on growth. The home-improvement retailer said fiscal 2019 sales growth would increase by 2.3%, down from its previous […]

Read More…

Bond Market Recession Signal …

◊ Business & Financial News – Stock Market News Today ◊  —  Stocks plunged on Wednesday, giving back Tuesday’s solid gains, after the U.S. bond market flashed a troubling signal about the U.S. economy. The Dow Jones Industrial Average dropped about 655 points or 2.3%, while the S&P 500 fell 2.3% and Nasdaq Composite declined 2.6%. […]

Read More…

U.S. Removes Some Items From China Tariff List

◊ Business & Financial News – Stock Market News Today ◊ ◊ US Removes Some Items From China Tariff List ◊ The United States Trade Representative office said Tuesday certain items were being removed from the new China tariff list because of “health, safety, national security and other factors” while tariffs on other items would […]

Read More…

Financial Markets – Top 5 Things to Watch This Week

◊ Financial Markets News – Stock Market News Today ◊ Start Trading Now or Try a FREE Demo Account Here’s what you need to know before start trading this week: This week investors will have a chance to parse a fresh batch of economic data to gain insights into the health of the global economy and whether […]

Read More…

Financial Markets: Turnaround Tuesday

◊ Financial Markets On Tuesday — August 6 ◊ Top Five Things You Need To Know In Financial Markets Today: 1. U.S. labels China “currency manipulator” The U.S. Treasury officially labeled China as a currency manipulator after the People’s Bank of China allowed the Chinese yuan to fall below 7 per dollar on Monday in […]

Read More…

Stocks Drop As Trade Battle Intensifies

> Stocks Drop – Stock Market News Today < U.S. futures and global stocks started the week with sharp declines and the yuan depreciated to a new low as President Trump’s threat to impose more tariffs on Chinese goods continued to rattle investors. The Stoxx Europe 600 was down 1.9%, led by losses in the […]

Read More…

Berkshire Hathaway Posts Rising Profit

Warren Buffett’s Berkshire Hathaway Inc. said second-quarter earnings rose due to unrealized investment gains, while the company’s cash pile grew to a record. Berkshire reported second-quarter net earnings of $14 billion, or $8,608 per Class A share equivalent, from $12 billion, or $7,301 a share, in the year-earlier period. Operating earnings, which exclude some investment […]

Read More…